Cancer Chemotherapy and Pharmacology

译名:癌症化疗与药理学

CANCER CHEMOTHERAPY AND PHARMACOLOGY

SCIEJCR Q3中科院4区

1-3

2026

影响因子区间

平台估算

投稿周期

24%

2025

中国作者发文占比

费用说明

收费

期刊简介:Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an eminent journal in the field. The primary focus in this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. It is essential reading for pharmacologists and oncologists giving results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy.

【译文】在实验和临床水平上解决广泛的药理学和肿瘤学问题,癌症化疗与药理学是一本杰出的期刊。在这个快速出版媒介中,主要关注新的抗癌药物,它们的实验筛选、临床前毒理学和药理学、单药和联合用药方式,以及临床I、II和III期试验。对于提供以下领域结果的药理学家和肿瘤学家来说是必读之物:临床毒理学、药代动力学、药效学、药物相互作用以及癌症治疗策略中的化疗适应症。

出版社
Springer Science+Business Media
语言
English
学科
医学
ISSN
0344-5704
eISSN
1432-0843
出版频率
月刊
创刊年份
1978
投稿网址
https://www.editorialmanager.com/ccap
最近更新
2026-04-02 18:16:40
Cancer Chemotherapy and Pharmacology

指标当前值近三年趋势
JCR分区Q3
暂无
中科院分区4区
暂无
影响因子区间1-3
暂无